Topical Bromfenac for Intraoperative Miosis and Pain Reduction

Summary

To evaluate the effect of bromfenac ophthalmic solution 0.09% for reduction of intraoperative miosis and pain in patient who have undergone femtosecond laser-assisted cataract surgery.

Timeline

Start

2018-03-01

Primary completion

2018-11-30

Completion

2019-03-30

Drugs

Indications